Revisiting thyroid hormones in schizophrenia

Journal of Thyroid Research

Volumn 2012, Issue , 2012, Pages

  Santos, Nadine Correia ^a,b   Costa, Patrício ^a,c   Ruano, Dina ^a,c   MacEdo, António ^d   Soares, Maria João ^d   Valente, José ^d   Pereira, Ana Telma ^d   Azevedo, Maria Helena ^d   Palha, Joana Almeida ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; CHLORPROMAZINE; CLOZAPINE; DOPAMINE; FLUPHENAZINE; FLUSPIRILENE; HALOPERIDOL; HOMOVANILLIC ACID; INTERLEUKIN 1; INTERLEUKIN 6; LIOTHYRONINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PROLACTIN; QUETIAPINE; RISPERIDONE; SEROTONIN; SEROTONIN 1A RECEPTOR; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIFLUOPERAZINE; TUMOR NECROSIS FACTOR ALPHA;

CEREBROSPINAL FLUID; COHORT ANALYSIS; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; DRUG EFFICACY; GABAERGIC SYSTEM; HEALTH STATUS; HOMEOSTASIS; HUMAN; HYPOPHYSIS THYROID SYSTEM; INFLAMMATION; MYELINATION; NERVE CELL NETWORK; NEUROIMAGING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE METABOLISM;

EID: 84879193013     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.1155/2012/569147     Document Type: Review

References (157)

1. Doyle L., Myxoedema: some early reports and contributions by British authors, 18731898. Journal of the Royal Society of Medicine 1991 84 2 103 106 2-s2.0-0026057111
2. Zoeller R. T., Rovet J., Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. Journal of Neuroendocrinology 2004 16 10 809 818 2-s2.0-8544225040 10.1111/j.1365-2826. 2004.01243.x (Pubitemid 39489993)
3. Bernal J., Thyroid hormone receptors in brain development and function. Nature Clinical Practice Endocrinology and Metabolism 2007 3 3 249 259 2-s2.0-33847216594 10.1038/ncpendmet0424
4. de Escobar G. M., Obregón M. J., del Rey F. E., Role of thyroid hormone during early brain development. European Journal of Endocrinology 2004 151 3 U25 U37 2-s2.0-10344260802 (Pubitemid 39627053)
5. Anderson G. W., Thyroid hormone and cerebellar development. Cerebellum 2008 7 1 60 74 2-s2.0-55749107647 10.1007/s12311-008-0021-4
6. Bernal J., Thyroid Hormones and Brain Development. Vitamins and Hormones 2005 71 95 122 2-s2.0-27744592731 10.1016/S0083-6729(05)71004-9 (Pubitemid 43589035)
7. Nunez J., Celi F. S., Ng L., Forrest D., Multigenic control of thyroid hormone functions in the nervous system. Molecular and Cellular Endocrinology 2008 287 1-2 1 12 2-s2.0-43549099941 10.1016/j.mce.2008.03.006
8. Chan S., Kilby M. D., Thyroid hormone and central nervous system development. Journal of Endocrinology 2000 165 1 1 8 2-s2.0-0034034328 (Pubitemid 30210560)
9. Porterfield S. P., Hendrich C. E., The role of thyroid hormones in prenatal and neonatal neurological development-Current perspectives. Endocrine Reviews 1993 14 1 94 106 2-s2.0-0027446957 10.1210/er.14.1.94 (Pubitemid 23066534)
10. de Escobar G. M., Obregón M. J., del Rey F. E., Maternal thyroid hormones early in prenancy and fetal brain development. Best Practice and Research 2004 18 2 225 248 2-s2.0-3042538236 10.1016/j.beem.2004.03.012 (Pubitemid 38807301)
11. De Long G. R., Stanbury J. B., Fierro-Benitez R., Neurological signs in congenital iodine-deficiency disorder (endemic cretinism). Developmental Medicine and Child Neurology 1985 27 3 317 324 2-s2.0-0021970929 (Pubitemid 15226272)
12. Ahmed O. M., El-Gareib A. W., El-bakry A. M., Abd El-Tawab S. M., Ahmed R. G., Thyroid hormones states and brain development interactions. International Journal of Developmental Neuroscience 2008 26 2 147 209 2-s2.0-38949131883 10.1016/j.ijdevneu.2007.09.011 (Pubitemid 351215070)
13. Bauer M., Heinz A., Whybrow P. C., Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Molecular Psychiatry 2002 7 2 140 156 2-s2.0-0036181205 10.1038/sj/mp/4000963 (Pubitemid 34177782)
14. Wiens S. C., Trudeau V. L., Thyroid hormone and γ -aminobutyric acid (GABA) interactions in neuroendocrine systems. Comparative Biochemistry and Physiology 2006 144 3 332 344 2-s2.0-33745478937 10.1016/j.cbpa.2006.01.033 (Pubitemid 43956566)
15. Mendes-de-Aguiar C. B., Alchini R., Decker H., Alvarez-Silva M., Tasca C. I., Trentin A. G., Thyroid hormone increases astrocytic glutamate uptake and protects astrocytes and neurons against glutamate toxicity. Journal of Neuroscience Research 2008 86 14 3117 3125 2-s2.0-57049106240 10.1002/jnr.21755
16. Collier D. A., Li T., The genetics of schizophrenia: glutamate not dopamine? European Journal of Pharmacology 2003 480 13 177 184 2-s2.0-0242499301 10.1016/j.ejphar.2003.08.105 (Pubitemid 37410370)
17. Kapur S., Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry 2003 160 1 13 23 2-s2.0-0037223711 10.1176/appi.ajp.160.1.13 (Pubitemid 36042420)
18. Carlsson A., The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006 39 1 S10 S14 2-s2.0-33644827689 10.1055/s-2006-931483 (Pubitemid 43357100)
19. Snyder S. H., Dopamine receptor excess and mouse madness. Neuron 2006 49 4 484 485 2-s2.0-32344451706 10.1016/j.neuron.2006.02.002 (Pubitemid 43221885)
20. Geyer M. A., Vollenweider F. X., Serotonin research: contributions to understanding psychoses. Trends in pharmacological sciences 2008 29 9 445 453 2-s2.0-55849099288 10.1016/j.tips.2008.06.006
21. MacDonald A. W., Schulz S. C., What we know: findings that every theory of Schizophrenia should explain. Schizophrenia Bulletin 2009 35 3 493 508 2-s2.0-65349088024 10.1093/schbul/sbp017
22. Davis K. L., Stewart D. G., Friedman J. I., Buchsbaum M., Harvey P. D., Hof P. R., Buxbaum J., Haroutunian V., White matter changes in schizophrenia evidence for myelin-related dysfunction. Archives of General Psychiatry 2003 60 5 443 456 2-s2.0-0038643584 10.1001/archpsyc.60.5.443 (Pubitemid 36539053)
23. Potvin S., Stip E., Sepehry A. A., Gendron A., Bah R., Kouassi E., Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biological Psychiatry 2008 63 8 801 808 2-s2.0-40949107708 10.1016/j.biopsych.2007.09.024 (Pubitemid 351410515)
24. Palha J. A., Goodman A. B., Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Research Reviews 2006 51 1 61 71 2-s2.0-33646889296 10.1016/j.brainresrev.2005.10.001 (Pubitemid 43782531)
25. Cheng S. Y., Leonard J. L., Davis P. J., Molecular aspects of thyroid hormone actions. Endocrine Reviews 2010 31 2 139 170 2-s2.0-77953639982 10.1210/er.2009-0007
26. Bunevicius R., Thyroid disorders in mental patients. Current Opinion in Psychiatry 2009 22 4 391 395 2-s2.0-67651011594 10.1097/YCO.0b013e328329e1ae
27. Valdivieso F. S., Kripper C., Ivelic J. A., Fardella C., Gloger S., Quiroz D., High prevalence of thyroid dysfunction among psychiatric inpatients. Revista Medica de Chile 2006 134 5 623 628 2-s2.0-33745665787 (Pubitemid 43972000)
28. Sim K., Chong S. A., Chan Y. H., Lum W. M., Thyroid dysfunction in chronic schizophrenia within a state psychiatric hospital. Annals of the Academy of Medicine Singapore 2002 31 5 641 644 2-s2.0-0036730715
29. Valle J., Ayuso-Gutierrez J. L., Abril A., Ayuso-Mateos J. L., Evaluation of thyroid function in lithium-naive bipolar patients. European Psychiatry 1999 14 6 341 345 2-s2.0-0033303678 10.1016/S0924-9338(99)00158-3
30. Placidi G. P., Boldrini M., Patronelli A., Flore E., Chiovato L., Perugi G., Marazziti D., Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology 1998 38 4 222 225 2-s2.0-0031768686 10.1159/000026545 (Pubitemid 28508629)
31. Rao M. L., Ruhrmann S., Retey B., Liappis N., Fuger J., Kraemer M., Kasper S., Möller H. J., Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry 1996 29 5 180 186 2-s2.0-0029792059 (Pubitemid 26315669)
32. Hickie I., Bennett B., Mitchell P., Wilhelm K., Orlay W., Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Australian and New Zealand Journal of Psychiatry 1996 30 2 246 252 2-s2.0-0030012402 (Pubitemid 26229637)
33. Othman S. S., Kadir K. A., Hassan J., Hong G. K., Singh B. B., Raman N., High prevalence of thyroid function test abnormalities in chronic schizophrenia. Australian and New Zealand Journal of Psychiatry 1994 28 4 620 624 2-s2.0-0028641656
34. Sabeen S., Chou C., Holroyd S., Abnormal thyroid stimulating hormone (TSH) in psychiatric long-term care patients. Archives of Gerontology and Geriatrics 2010 51 1 6 8 2-s2.0-77953285674 10.1016/j.archger.2009.06.002
35. Marian G., Nica E. A., Ionescu B. E., Ghinea D., Hyperthyroidismcause of depression and psychosis: a case report. Journal of medicine and life 2009 2 4 440 442 2-s2.0-77951635057
36. Snabboon T., Khemkha A., Chaiyaumporn C., Lalitanantpong D., Sridama V., Psychosis as the first presentation of hyperthyroidism. Internal and Emergency Medicine 2009 4 4 359 360 2-s2.0-70350620303 10.1007/s11739-009-0259-y
37. Benvenga S., Lapa D., Trimarchi F., Don't forget the thyroid in the etiology of psychoses. American Journal of Medicine 2003 115 2 159 160 2-s2.0-0043238902 10.1016/S0002-9343(03)00298-5 (Pubitemid 37288850)
38. Bahls S. C., de Carvalho G. A., The relation between thyroid function and depression: a review. Revista Brasileira de Psiquiatria 2004 26 1 41 49 2-s2.0-1842424498 (Pubitemid 38419358)
39. Fountoulakis K. N., Kantartzis S., Siamouli M., Panagiotidis P., Kaprinis S., Iacovides A., Kaprinis G., Peripheral thyroid dysfunction in depression. World Journal of Biological Psychiatry 2006 7 3 131 137 2-s2.0-33746494118 10.1080/15622970500474739 (Pubitemid 44137013)
40. Abraham G., Milev R., Stuart Lawson J., T3 augmentation of SSRI resistant depression. Journal of Affective Disorders 2006 91 2-3 211 215 2-s2.0-33644998292 10.1016/j.jad.2006.01.013
41. Abulseoud O., Sane N., Cozzolino A., Kiriakos L., Mehra V., Gitlin M., Masseling S., Whybrow P., Altshuler L. L., Mintz J., Frye M. A., Free T4 index and clinical outcome in patients with depression. Journal of Affective Disorders 2007 100 13 271 277 2-s2.0-34249286563 10.1016/j.jad.2006.10.012 (Pubitemid 46818438)
42. Brouwer J. P., Appelhof B. C., Hoogendijk W. J. G., Huyser J., Endert E., Zuketto C., Schene A. H., Tijssen J. G. P., Van Dyck R., Wiersinga W. M., Fliers E., Thyroid and adrenal axis in major depression: a controlled study in outpatients. European Journal of Endocrinology 2005 152 2 185 191 2-s2.0-20044372332 10.1530/eje.1.01828 (Pubitemid 40309563)
43. Chueire V. B., Romaldini J. H., Ward L. S., Subclinical hypothyroidism increases the risk for depression in the elderly. Archives of Gerontology and Geriatrics 2007 44 1 21 28 2-s2.0-33751025091 10.1016/j.archger.2006.02.001 (Pubitemid 44755445)
44. Gunnarsson T., Sjöberg S., Eriksson M., Nordin C., Depressive symptoms in hypothyroid disorder with some observations on biochemical correlates. Neuropsychobiology 2001 43 2 70 74 2-s2.0-0035125409 10.1159/000054869 (Pubitemid 32149728)
45. Sullivan P. F., Wilson D. A., Mulder R. T., Joyce P. R., The hypothalamic-pituitary-thyroid axis in major depression. Acta Psychiatrica Scandinavica 1997 95 5 370 378 2-s2.0-0030971771 (Pubitemid 27244834)
46. Kirkegaard C., Faber J., Free thyroxine and 3, 3′5′ -triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinologica 1991 124 2 166 172 2-s2.0-0026033764
47. Wiersinga W. M., Do we need still more trials on T4 and T3 combination therapy in hypothyroidism? European Journal of Endocrinology 2009 161 6 955 959 2-s2.0-72949123467 10.1530/EJE-09-0879
48. Pae C. U., Mandelli L., Han C., Ham B. J., Masand P. S., Patkar A. A., Steffens D. C., De Ronchi D., Serretti A., Thyroid hormones affect recovery from depression during antidepressant treatment. Psychiatry and Clinical Neurosciences 2009 63 3 305 313 2-s2.0-65649142031 10.1111/j.1440-1819.2009. 01938.x
49. Rack S. K., Makela E. H., Hypothyroidism and depression: a therapeutic challenge. Annals of Pharmacotherapy 2000 34 10 1142 1145 2-s2.0-0033770254
50. Kirkegaard C., Faber J., The role of thyroid hormones in depression. European Journal of Endocrinology 1998 138 1 1 9 2-s2.0-0031937517 10.1530/eje.0.1380001 (Pubitemid 28078802)
51. Aronson R., Offman H. J., Joffe R. T., David Naylor C., Triiodothyronine augmentation in the treatment of refractory depression: a meta-analysis. Archives of General Psychiatry 1996 53 9 842 848 2-s2.0-0029786561 (Pubitemid 26303624)
52. Altshuler L. L., Bauer M., Frye M. A., Gitlin M. J., Mintz J., Szuba M. P., Leight K. L., Whybrow P. C., Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. American Journal of Psychiatry 2001 158 10 1617 1622 2-s2.0-0034817297 10.1176/appi.ajp.158.10.1617 (Pubitemid 32923653)
53. Mebis L., van den Berghe G., The hypothalamus-pituitary-thyroid axis in critical illness. Netherlands Journal of Medicine 2009 67 10 332 340 2-s2.0-70549089773
54. Rinieris P., Christodoulou G. N., Souvatzoglou A., Free-thyroxine index in schizophrenic patients before and after neuroleptic treatment. Neuropsychobiology 1980 6 1 29 33 2-s2.0-0018905607 (Pubitemid 10136165)
55. Rao M. L., Gross G., Huber G., Altered interrelationship of dopamine, prolactin, thyrotropin and thyroid hormone in schizophrenic patients. European Archives of Psychiatry and Neurological Sciences 1984 234 1 8 12 2-s2.0-0021592769 (Pubitemid 14006902)
56. Martinos A., Rinieris P., Souvatzoglou A., Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients. Neuropsychobiology 1986 16 2-3 72 77 2-s2.0-0022893549 (Pubitemid 17049763)
57. Mason J. W., Kennedy J. L., Kosten T. R., Giller E. L., Serum thyroxine levels in schizophrenic and affective disorder diagnostic subgroups. The Journal of Nervous and Mental Disease 1989 177 6 351 358 2-s2.0-0024400076 (Pubitemid 19159344)
58. Southwick S., Mason J. W., Giller E. L., Kosten T. R., Serum thyroxine change and clinical recovery in psychiatric inpatients. Biological Psychiatry 1989 25 1 67 74 2-s2.0-0024494986 (Pubitemid 19030225)
59. Rao M. L., Gross G., Strebel B., Braunig P., Huber G., Klosterkotter J., Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Research 1990 34 3 243 257 2-s2.0-0025651921 10.1016/0165-1781(90)90003-N
60. Roca R. P., Blackman M. R., Ackerley M. B., Harman S. M., Gregerman R. I., Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. Endocrine Research 1990 16 4 415 447 2-s2.0-0025569676
61. Walch T. J., Enhancing compliance in schizophrenic patients by weekly dosing with levothyroxine sodium. Journal of Clinical Psychiatry 1994 55 12 543 2-s2.0-0028560324
62. Rao M. L., Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia. Psychiatry Research 1995 57 1 21 39 2-s2.0-0029000888 10.1016/0165-1781(95)02525-2
63. Baumgartner A., Pietzcker A., Gaebel W., The hypothalamic-pituitary- thyroid axis in patients with schizophrenia. Schizophrenia Research 2000 44 3 233 243 2-s2.0-0034284017 10.1016/S0920-9964(99)00187-5 (Pubitemid 30657960)
64. Yazici K., Yazici A. E., Taneli B., Different neuroendocrine profiles of remitted and nonremitted schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002 26 3 579 584 2-s2.0-0036197150 10.1016/S0278-5846(01)00311-6 (Pubitemid 34252954)
65. Kelly D. L., Conley R. R., Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. The Journal of clinical psychiatry 2005 66 1 80 84 2-s2.0-13844312732
66. De Jong F. J., den Heijer T., Visser T. J., De Rijke Y. B., Drexhage H. A., Hofman A., Breteler M. M. B., Thyroid hormones, dementia, and atrophy of the medial temporal lobe. Journal of Clinical Endocrinology and Metabolism 2006 91 7 2569 2573 2-s2.0-33745771349 10.1210/jc.2006-0449 (Pubitemid 44024619)
67. Asher R., Myxoedematous madness. British Medical Journal 1949 2 4627 555 562
68. Bursten B., Psychoses associated with thyrotoxicosis. Archives of General Psychiatry 1961 4 267 273 2-s2.0-0004762991
69. Kline N. S., Blair J., Cooper T. B., Esser A. H., Hackett E., Vestergaard P., A controlled sevn year study of endocrine and other indices in drug treated chronic schizophrenics. Acta Psychiatrica Scandinavica, Supplement 1968 206 7 75 2-s2.0-0014397986
70. Palha J. A., Ruano D., Santos N. C., Circulating Thyroid Hormones in Schizophrenia 2010 San Diego, Calif, USA Society for Neurosciences
71. Schmitz T., Chew L. J., Cytokines and myelination in the central nervous system. The Scientific World Journal 2008 8 1119 1147 2-s2.0-56749175020 10.1100/tsw.2008.140
72. Laruelle M., Abi-Dargham A., Gil R., Kegeles L., Innis R., Increased dopamine transmission in schizophrenia: relationship to illness phases. Biological Psychiatry 1999 46 1 56 72 2-s2.0-0032987267 10.1016/S0006-3223(99) 00067-0 (Pubitemid 29296818)
73. Laruelle M., Abi-Dargham A., van Dyck C. H., Gil R., D'Souza C. D., Erdos J., Mccance E., Rosenblatt W., Fingado C., Zoghbi S. S., Baldwin R. M., Seibyl J. P., Krystal J. H., Charney D. S., Innis R. B., Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the United States of America 1996 93 17 9235 9240 2-s2.0-0029787944
74. Crocker A. D., Overstreet D. H., Crocker J. M., Hypothyroidism leads to increased dopamine receptor sensitivity and concentration. Pharmacology Biochemistry and Behavior 1986 24 6 1593 1597 (Pubitemid 16066620)
75. Crocker A. D., Overstreet D. H., Modification of the behavioural effects of haloperidol and of dopamine receptor regulation by altered thyroid status. Psychopharmacology 1984 82 1-2 102 106 2-s2.0-0021369908 (Pubitemid 14222294)
76. Diarra A., Lefauconnier J. M., Valens M., Georges P., Gripois D., Tyrosine content, influx and accumulation rate, and catecholamine biosynthesis measured in vivo, in the central nervous system and in peripheral organs of the young rat. Influence of neonatal hypo- and hyperthyroidism. Archives Internationales de Physiologie et de Biochimie 1989 97 5 317 332 2-s2.0-0024332894 (Pubitemid 20000606)
77. Chaube R., Joy K. P., Thyroid hormone modulation of brain in vivo tyrosine hydroxylase activity and kinetics in the female catfish Heteropneustes fossilis. Journal of Endocrinology 2003 179 2 205 215 2-s2.0-0345329866 10.1677/joe.0.1790205 (Pubitemid 37461350)
78. Shikaeva F. V., Koreneva G. P., Functional interrelations of monoamines, thyrotropic hormone and thyroid hormones in hyperprolactinemia. Problemy Endokrinologii 1987 33 4 27 30 2-s2.0-0023378135
79. Magliozzi J. R., Gold A., Laubly J. N., Effect of oral administration of haloperidol on plasma thyrotropin concentrations in men. Psychoneuroendocrinology 1989 14 1-2 125 130 2-s2.0-0024559310 (Pubitemid 19110836)
80. Kundu S., Biswas A., Roy S., De J., Pramanik M., Ray A. K., Thyroid hormone homeostasis in brain: possible involvement of adrenergic phenomenon in adult rat. Neuroendocrinology 2009 89 2 140 151 2-s2.0-61749092315 10.1159/000158715
81. Woolley D. W., Shaw E., A biochemical and pharmacological suggestion about certain mental disorders. Proceedings of the National Academy of Sciences of the United State 1954 40 4 228 231
82. Meltzer H. Y., herbert.meltzer@vanderbilt.edu Massey B. W., The role of serotonin receptors in the action of atypical antipsychotic drugs. Current Opinion in Pharmacology 2011 11 1 59 67 10.1016/j.coph.2011.02.007
83. Abi-Dargham A., Alterations of serotonin transmission in schizophrenia. International Review of Neurobiology 2007 78 133 164 2-s2.0-33847345013 10.1016/S0074-7742(06)78005-9
84. Shin J. K., Malone D. T., Crosby I. T., ian.crosby@monash.edu Capuano B., ben.capuano@monash.edu Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action. Current Medicinal Chemistry 2011 18 9 1380 1404 10.2174/092986711795029546
85. Abi-Dargham A., Laruelle M., Aghajanian G. K., Charney D., Krystal J., The role of serotonin in the pathophysiology and treatment of schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences 1997 9 1 1 17 2-s2.0-0031034035 (Pubitemid 27075408)
86. Strawn J. R., Ekhator N. N., D'Souza B. B., Geracioti T. D., Pituitary-thyroid state correlates with central dopaminergic and serotonergic activity in healthy humans. Neuropsychobiology 2004 49 2 84 87 2-s2.0-1342269751 10.1159/000076415 (Pubitemid 38253133)
87. Cleare A. J., McGregor A., O'Keane V., Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clinical Endocrinology 1995 43 6 713 719 2-s2.0-0029590243 (Pubitemid 26016802)
88. Cleare A. J., McGregor A., Chambers S. M., Dawling S., O'Keane V., Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism. Neuroendocrinology 1996 64 1 65 69 2-s2.0-0029928968 (Pubitemid 26184096)
89. Gold P. W., Goodwin F. K., Wehr T., Rebar R., Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites. American Journal of Psychiatry 1977 134 9 1028 1031 2-s2.0-0017671411 (Pubitemid 8196333)
90. Peabody C. A., Whiteford H. A., Warner M. D., TRH stimulation test and depression. Psychiatry Research 1987 22 1 21 28 2-s2.0-0023201294 (Pubitemid 17144546)
91. Blier P., de Montigny C., Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences 1994 15 7 220 226 2-s2.0-0028287265 10.1016/0165-6147(94)90315-8 (Pubitemid 24210726)
92. Ito J. M., Valcana T., Timiras P. S., Effect of hypo- and hyperthyroidism on regional monoamine metabolism in the adult rat brain. Neuroendocrinology 1977 24 1 55 64 2-s2.0-0017589384 (Pubitemid 8264807)
93. Upadhyaya L., Agrawal J. K., Effect of L-thyroxine and carbimazole on brain biogenic amines and amino acids in rats. Endocrine Research 1993 19 2-3 87 99 2-s2.0-0027258087 (Pubitemid 23262248)
94. Jacoby J. H., Mueller G., Wurtman R. J., Thyroid state and brain monoamine metabolism. Endocrinology 1975 97 5 1332 1335 2-s2.0-0016723580
95. Tejani-Butt S. M., Yang J., Kaviani A., Time course of altered thyroid states on 5-HT(1A) receptors and 5-HT uptake sites in rat brain: an autoradiographic analysis. Neuroendocrinology 1993 57 6 1011 1018 2-s2.0-0027290966 (Pubitemid 23260777)
96. Kulikov A., Moreau X., Jeanningros R., Effects of experimental hypothyroidism on 5-HT(1A), 5-HT(2A) receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain. Neuroendocrinology 1999 69 6 453 459 2-s2.0-0032983219 10.1159/000054449 (Pubitemid 29273912)
97. Mason G. A., Bondy S. C., Nemeroff C. B., The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain. Psychoneuroendocrinology 1987 12 4 261 270 2-s2.0-0023225893 (Pubitemid 17138224)
98. Javitt D. C., Zukin S. R., Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 1991 148 10 1301 1308 2-s2.0-0025952455
99. Javitt D. C., Glutamatergic theories of schizophrenia. Israel Journal of Psychiatry and Related Sciences 2010 47 1 4 16 2-s2.0-77953188782
100. Mohn A. R., Gainetdinov R. R., Caron M. G., Koller B. H., Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999 98 4 427 436 2-s2.0-0033588176 10.1016/S0092-8674(00)81972-8 (Pubitemid 29402481)
101. Arufe M. C., Duran R., Perez-Vences D., Alfonso M., Endogenous excitatory amino acid neurotransmission regulates thyroid-stimulating hormone and thyroid hormone secretion in conscious freely moving male rats. Endocrine 2002 17 3 193 197 2-s2.0-0035987874 10.1385/ENDO:17:3:193 (Pubitemid 34701364)
102. Mannisto P. T., Mattila J., Tuominen R. K., Vesalainen S., Effect of some putative amino acid neurotransmitters on the stimulated TSH secretion in male rats. Hormone Research 1983 17 1 19 26 2-s2.0-0020646989 (Pubitemid 13193359)
103. Brann D. W., Glutamate: a major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology 1995 61 3 213 225 2-s2.0-0028898781
104. Lewis D. A., Hashimoto T., Volk D. W., Cortical inhibitory neurons and schizophrenia. Nature Reviews Neuroscience 2005 6 4 312 324 2-s2.0-16344372645 10.1038/nrn1648 (Pubitemid 40469985)
105. Akbarian S., Huang H. S., Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Research Reviews 2006 52 2 293 304 2-s2.0-33747872904 10.1016/j.brainresrev.2006.04.001 (Pubitemid 44291805)
106. Berbel P., Marco P., Cerezo J. R., DeFelipe J., Distribution of parvalbumin immunoreactivity in the neocortex of hypothyroid adult rats. Neuroscience Letters 1996 204 1-2 65 68 2-s2.0-0030064165 10.1016/0304-3940(96) 12318-1 (Pubitemid 26053675)
107. Virgili M., Saverino O., Vaccari M., Barnabei O., Contestabile A., Temporal, regional and cellular selectivity of neonatal alteration of the thyroid state on neurochemical maturation in the rat. Experimental Brain Research 1991 83 3 555 561 2-s2.0-0026016902
108. Patel A. J., Hayashi M., Hunt A., Role of thyroid hormone and nerve growth factor in the development of choline acetyltransferase and other cell-specific marker enzymes in the basal forebrain of the rat. Journal of Neurochemistry 1988 50 3 803 811 2-s2.0-0023851578 (Pubitemid 18060409)
109. Honegger P., Lenoir D., Triiodothyronine enhancement of neuronal differentiation in aggregating fetal rat brain cells cultured in a chemically defined medium. Brain Research 1980 199 2 425 434 2-s2.0-0018909903 10.1016/0006-8993(80)90699-X (Pubitemid 10055944)
110. Balázs R., Kovács S., Teichgräber P., Cocks W. A., Eayrs J. T., Biochemical effects of thyroid deficiency on the developing brain. Journal of Neurochemistry 1968 15 11 1335 1349
111. García Argiz C. A., Pasquini J. M., Kaplún B., Gómez C. J., Hormonal regulation of brain development II. Effect of neonatal thyroidectomy on succinate dehydrogenase and other enzymes in developing cerebral cortex and cerebellum of the rat. Brain Research 1967 6 4 635 646
112. Krawiec L., Garcia Argiz C. A., Gomez C. J., Hormonal regulation of brain development. 3. Effects of triiodothyronine and growth hormone on the biochemical changes in the cerebral cortex and cerebellum of neonatally thyroidectomized rats. Brain Research 1969 15 1 209 218
113. Ramírez G., Gómez C. J., Influence of neonatal hypothyroidism on amino acids in developing rat brain. Journal of Neurochemistry 1966 13 10 1017 1025
114. Messer A., Eisenberg B., Martin D. L., Effects of mild hyperthyroidism on levels of amino acids in the developing lurcher cerebellum. Journal of Neurogenetics 1989 5 1 77 85 2-s2.0-0024493619
115. Chapa F., Kunnecke B., Calvo R., Del Rey F. E., De Escobar G. M., Cerdan S., Adult-onset hypothyroidism and the cerebral metabolism of (1,2-13C2) acetate as detected by 13C nuclear magnetic resonance. Endocrinology 1995 136 1 296 305 2-s2.0-0028797115
116. Hashimoto H., Walker C. H., Prange A. J. Jr., Mason G. A., The effects of thyroid hormones on potassium-stimulated release of 3H-GABA by synaptosomes of rat cerebral cortex. Neuropsychopharmacology 1991 5 1 49 54 2-s2.0-0025915713
117. A receptor complex of brain. Neuroscience 1996 73 3 705 713 2-s2.0-0030218057 10.1016/0306-4522(96)00052-8 (Pubitemid 26260934)
118. A receptors. European Journal of Pharmacology 1998 349 1 115 121 2-s2.0-0032524574 10.1016/S0014-2999(98)00182-4 (Pubitemid 28270664)
119. Ahmed O. M., Abd El-Tawab S. M., Ahmed R. G., Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions. International Journal of Developmental Neuroscience 2010 28 6 437 454 2-s2.0-77955468569 10.1016/j.ijdevneu.2010.06.007
120. Dean B., Boer S., Gibbons A., Money T., Scarr E., Recent advances in postmortem pathology and neurochemistry in schizophrenia. Current Opinion in Psychiatry 2009 22 2 154 160 2-s2.0-62349095315 10.1097/YCO.0b013e328323d52e
121. Fatemi S. H., Folsom T. D., Reutiman T. J., Abu-Odeh D., Mori S., Huang H., Oishi K., Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice. Schizophrenia Research 2009 112 13 46 53 2-s2.0-67349188747 10.1016/j.schres.2009.04.014
122. Hakak Y., Walker J. R., Li C., Wong W. H., Davis K. L., Buxbaum J. D., Haroutunian V., Fienberg A. A., Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2001 98 8 4746 4751 2-s2.0-0035836642 10.1073/pnas.081071198 (Pubitemid 32295047)
123. Katsel P., Davis K. L., Li C., Tan W., Greenstein E., Kleiner Hoffman L. B., Haroutunian V., Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology 2008 33 12 2993 3009 2-s2.0-53949100073 10.1038/npp.2008.19
124. Farsetti A., Desvergne B., Hallenbeck P., Robbins J., Nikodem V. M., Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. Journal of Biological Chemistry 1992 267 22 15784 15788 2-s2.0-0026718829
125. Ibarrola N., Rodríguez-Pea A., Hypothyroidism coordinately and transiently affects myelin protein gene expression in most rat brain regions during postnatal development. Brain Research 1997 752 1-2 285 293 2-s2.0-0342437522 10.1016/S0006-8993(96)01480-1 (Pubitemid 27143925)
126. Kip2 in the intracellular timer that controls oligodendrocyte differentiation. Journal of Neuroscience 2007 27 23 6185 6196 2-s2.0-34250012532 10.1523/JNEUROSCI.0628-07.2007 (Pubitemid 46890015)
127. Dugas J. C., Tai Y. C., Speed T. P., Ngai J., Barres B. A., Functional genomic analysis of oligodendrocyte differentiation. Journal of Neuroscience 2006 26 43 10967 10983 2-s2.0-33751099047 10.1523/JNEUROSCI.2572-06.2006 (Pubitemid 44772187)
128. Fan X., Goff D. C., Henderson D. C., Inflammation and schizophrenia. Expert Review of Neurotherapeutics 2007 7 7 789 796 2-s2.0-34447131488 10.1586/14737175.7.7.789 (Pubitemid 47037719)
129. Boelen A., Platvoet-Ter Schiphorst M. C., Wiersinga W. M., Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 1993 77 6 1695 1699 2-s2.0-0027131203 10.1210/jc.77.6.1695 (Pubitemid 24000937)
130. Boelen A., Schiphorst M. C. P. T., Wiersinga W. M., Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease. Journal of Clinical Endocrinology and Metabolism 1995 80 3 971 976 2-s2.0-0028956194
131. Kwakkel J., Wiersinga W. M., Boelen A., Interleukin-1 β modulates endogenous thyroid hormone receptor α gene transcription in liver cells. Journal of Endocrinology 2007 194 2 257 265 2-s2.0-34547860383 10.1677/JOE-06-0177 (Pubitemid 47249664)
132. Boelen A., Kwakkel J., Alkemade A., Renckens R., Kaptein E., Kuiper G., Wiersinga W. M., Visser T. J., Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology 2005 146 12 5128 5134 2-s2.0-27844524943 10.1210/en.2005-0608 (Pubitemid 41653026)
133. Dratman M. B., Crutchfield F. L., Axelrod J., Localization of triiodothyronine in nerve ending fractions of rat brain. Proceedings of the National Academy of Sciences of the United States of America 1976 73 3 941 944 2-s2.0-0017239591
134. Rozanov C. B., Dratman M. B., Immunohistochemical mapping of brain triiodothyronine reveals prominent localization in central noradrenergic systems. Neuroscience 1996 74 3 897 915 2-s2.0-0030564950 10.1016/0306-4522(96) 00186-8 (Pubitemid 26285825)
135. Trentin A. G., Thyroid hormone and astrocyte morphogenesis. Journal of Endocrinology 2006 189 2 189 197 2-s2.0-33646764917 10.1677/joe.1.06680
136. Scanlan T. S., Minireview: 3-iodothyronamine (T1AM): a new player on the thyroid endocrine team? Endocrinology 2009 150 3 1108 1111 2-s2.0-67649884432 10.1210/en.2008-1596
137. Dratman M. B., Crutchfield F. L., Synaptosomal [125I]triiodothyronine after intravenous [125I]thyroxine. The American Journal of Physiology 1978 235 6 E638 E647 2-s2.0-0018113470
138. Kastellakis A., Valcana T., Characterization of thyroid hormone transport in synaptosomes from rat brain. Molecular and Cellular Endocrinology 1989 67 2-3 231 241 2-s2.0-0024330759 10.1016/0303-7207(89)90213-X (Pubitemid 20008208)
139. Mason G. A., Walker C. H., Prange A. J. Jr., L-triiodothyronine: is this peripheral hormone a central neurotransmitter? Neuropsychopharmacology 1993 8 3 253 258 2-s2.0-0027162723 (Pubitemid 23151393)
140. Scanlan T. S., Suchland K. L., Hart M. E., Chiellini G., Huang Y., Kruzich P. J., Frascarelli S., Crossley D. A., Bunzow J. R., Ronca-Testoni S., Lin E. T., Hatton D., Zucchi R., Grandy D. K., 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nature Medicine 2004 10 6 638 642 2-s2.0-2942731384 10.1038/nm1051 (Pubitemid 38796856)
141. Zucchi R., Chiellini G., Scanlan T. S., Grandy D. K., Trace amine-associated receptors and their ligands. British Journal of Pharmacology 2006 149 8 967 978 2-s2.0-33845637306 10.1038/sj.bjp.0706948 (Pubitemid 44950800)
142. Eravci M., Pinna G., Meinhold H., Baumgartner A., Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain. Endocrinology 2000 141 3 1027 1040 2-s2.0-0034455252 10.1210/en.141.3.1027 (Pubitemid 32266070)
143. de Leon J., Glucuronidation enzymes, genes and psychiatry. International Journal of Neuropsychopharmacology 2003 6 1 57 72 2-s2.0-0037345011 10.1017/S1461145703003249 (Pubitemid 36373101)
144. Ng L., Goodyear R. J., Woods C. A., Schneider M. J., Diamond E., Richardson G. P., Kelley M. W., St. Germain D.L. D. L., Galton V. A., Forrest D., Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proceedings of the National Academy of Sciences of the United States of America 2004 101 10 3474 3479 2-s2.0-12144291224 10.1073/pnas.0307402101 (Pubitemid 38338219)
145. Marsh-Armstrong N., Huang H., Remo B. F., Liu T. T., Brown D. D., Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase. Neuron 1999 24 4 871 878 2-s2.0-0033372525 (Pubitemid 30017666)
146. Holmes E., Tsang T. M., Huang J. T., Leweke F. M., Koethe D., Gerth C. W., Nolden B. M., Gross S., Schreiber D., Nicholson J. K., Bahn S., sb209@cam.ac.uk Metabolic profiling of csf: evidence that early intervention may impact on disease progression and outcome in schizophrenia. Public Library of Science Medicine 2006 3 8, article e327 10.1371/journal.pmed.0030327 (Pubitemid 44338380)
147. Schwarz E., Bahn S., Cerebrospinal fluid: identification of diagnostic markers for schizophrenia. Expert Review of Molecular Diagnostics 2008 8 2 209 216 2-s2.0-41549164882 10.1586/14737159.8.2.209 (Pubitemid 351469440)
148. Sampaolo S., Campos-Barros A., Mazziotti G., Carlomagno S., Sannino V., Amato G., Carella C., Di Iorio G., Increased cerebrospinal fluid levels of 3,3′5′- triiodothyronine in patients with Alzheimer's disease. Journal of Clinical Endocrinology and Metabolism 2005 90 1 198 202 2-s2.0-12244290310 10.1210/jc.2004-1083 (Pubitemid 40116657)
149. Lavado-Autric R., Ausó E., García-Velasco J. V., Del Carmen Arufe M., Escobar del Rey F., Berbel P., Morreale de Escobar G., gmorreale@iib.uam.es Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. Journal of Clinical Investigation 2003 111 7 1073 1082 10.1172/JCI200316262 (Pubitemid 36397484)
150. Ausó E., Lavado-Autric R., Cuevas E., Escobar Del Rey F., Morreale De Escobar G., Berbel P., A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004 145 9 4037 4047 2-s2.0-3242666436 10.1210/en.2004-0274 (Pubitemid 39120549)
151. Cuevas E., Ausó E., Telefont M., Morreale De Escobar G., Sotelo C., Berbel P., Transient maternal hypothyroxinemia at onset of corticogenesis alters tangential migration of medial ganglionic eminence-derived neurons. European Journal of Neuroscience 2005 22 3 541 551 2-s2.0-23944497570 10.1111/j.1460-9568.2005.04243.x (Pubitemid 41192265)
152. Costeira M. J., Oliveira P., Santos N. C., Ares S., Saenz-Rico B., De Escobar G. M., Palha J. A., japalha@ecsaude.uminho.pt Psychomotor development of children from an iodine-deficient region. Journal of Pediatrics 2011 159 3 447 453 10.1016/j.jpeds.2011.02.034
153. de Escobar G. M., Obregón M. J., Del Rey F. E., Iodine deficiency and brain development in the first half of pregnancy. Public Health Nutrition A 2007 10 12 1554 1570 2-s2.0-36849050817 10.1017/S1368980007360928 (Pubitemid 350224313)
154. Fisher D. A., Dussault J. H., Foley T. P. Jr., Screening for congenital hypothyroidism: results of screening one million North American infants. Journal of Pediatrics 1979 94 5 700 705 2-s2.0-0018390505 (Pubitemid 9135485)
155. Rovet J. F., Ehrlich R. M., Sorbara D. L., Neurodevelopment in infants and preschool children with congenital hypothyroidism: etiological and treatment factors affecting outcome. Journal of Pediatric Psychology 1992 17 2 187 213 2-s2.0-0026703399
156. Rodrigues A. J., Leão P., Pêgo J. M., Cardona D., Carvalho M. M., Oliveira M., Costa B. M., Carvalho A. F., Morgado P., Araújo D., Palha J. A., Almeida O. F.X., Sousa N., Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids. Molecular Psychiatry. In press 10.1038/mp.2011.126
157. Oliveira M., mariooliveira@ecsaude.uminho.pt Leão P., Rodrigues A.-J., Pêgo J.-M., Cerqueira J.-J., Sousa N., Programming effects of antenatal corticosteroids exposure in male sexual behavior. Journal of Sexual Medicine 2011 8 7 1965 1974 10.1111/j.1743-6109.2010.02170.x